Cite
Organ preservation with targeted rapamycin nanoparticles: a pre-treatment strategy preventing chronic rejection in vivo
MLA
Patterson Allen, et al. “Organ Preservation with Targeted Rapamycin Nanoparticles: A Pre-Treatment Strategy Preventing Chronic Rejection in Vivo.” RSC Advances, vol. 8, Jan. 2018, pp. 25909–19. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....58fb9cba1cd9e1627ab42a668e7adc75&authtype=sso&custid=ns315887.
APA
Patterson Allen, Suraj Dixit, Danh T. Tran, Kunal Patel, Alfred Moore, Kayla Miller, Qi Cheng, Carl Atkinson, Yu-Lin Jiang, Satish N. Nadig, Grace Bazzle, Scott Esckilsen, Peng Zhu, & Ann-Marie Broome. (2018). Organ preservation with targeted rapamycin nanoparticles: a pre-treatment strategy preventing chronic rejection in vivo. RSC Advances, 8, 25909–25919.
Chicago
Patterson Allen, Suraj Dixit, Danh T. Tran, Kunal Patel, Alfred Moore, Kayla Miller, Qi Cheng, et al. 2018. “Organ Preservation with Targeted Rapamycin Nanoparticles: A Pre-Treatment Strategy Preventing Chronic Rejection in Vivo.” RSC Advances 8 (January): 25909–19. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....58fb9cba1cd9e1627ab42a668e7adc75&authtype=sso&custid=ns315887.